Alternatives to a Testing Service: What People Actually Want
People buying a testing service usually want one of five things, and for four of them there is a cheaper and better route.
The Short Answer
Before comparing testing services it is worth identifying what you are buying, because people paying for one usually want one of five distinct things: access to analytes routine care will not order, convenience, interpretation, a longitudinal record, or reassurance. Only the first genuinely requires a consumer testing service in most systems, and for the other four there are cheaper and often better routes. Providers and prices change continuously, so this covers the alternatives rather than current comparisons.
Want One: Access to Specific Analytes
This is the legitimate case, and it is narrower than a full panel.
The analytes routine care commonly omits and that change decisions: apolipoprotein B, lipoprotein(a) once in a lifetime, fasting insulin, and a urine albumin to creatinine ratio. Free T4 alongside TSH, and thyroid peroxidase antibodies once, are frequently omitted too.
The cheapest routes, in rough order: ask your usual clinician directly, since these are inexpensive standard tests and the request is often granted when the reason is stated. Where a system permits, self-referred laboratory testing through the same laboratories clinicians use, which is frequently cheaper than a consumer service reselling it. A consumer service where neither is available, choosing analytes rather than a package.
What makes the request more likely to succeed: naming the specific test and the reason, mentioning family history where relevant, and asking for lipoprotein(a) as a one-off rather than a repeat. Clinicians decline broad panels more readily than specific justified additions.
Many people have never asked, and asking is free.
Want Two: Convenience
| Convenience feature | Cost |
|---|---|
| Home finger-prick collection | Haemolysis, small volume, dilution from squeezing; several analytes affected |
| Posted sample | Homocysteine rises in transit, potassium shifts, glucose falls without preservative |
| No appointment needed | No clinician involvement, so no route for a serious result |
| Fast results | Usually genuine, and rarely the constraint on a decision |
| App-based reporting | Often a score rather than numbers, which is a loss rather than a gain |
Convenience is real and it has costs that are specific rather than theoretical. For anything you intend to act on, a venous draw at a laboratory is better, and the inconvenience is one appointment.
The posted-sample issue is worth emphasising because it produces results people then act on. A kit collected on a Friday and processed on a Tuesday can give a misleading potassium, homocysteine or glucose, and there is no flag on the report saying so.
Want Three: Interpretation
This is the want most people have and least recognise, and a testing service is a poor way to buy it.
Why: interpretive reports are generated at scale, frequently emphasise flags rather than patterns, and where the service sells products the interpretation is not independent of the catalogue.
Better routes: a clinician appointment specifically to review results you already have, which is often cheaper than a large panel and considerably more useful. Learning to read your own panel, which is genuinely learnable and is what much of this Journal exists for. And reading patterns rather than flags, since six mildly abnormal values indicating insulin resistance is one finding rather than six.
What good interpretation actually involves: reading position within ranges rather than flags, checking the conditions the sample was drawn under, comparing to your own previous values rather than to a population, identifying the upstream pattern, and separating what needs action from what needs repeating.
None of that requires a subscription, and most of it requires knowing the questions rather than buying an answer.
Want Four: A Longitudinal Record
A frequent and reasonable motivation, and a service is not the way to get it.
The problem with buying it as a service: the record lives with the provider, in their format, often as scores rather than numbers, and it ends when you stop subscribing or they change their offering. If you cannot export it, the asset belongs to them.
What actually builds a record: requesting your own past medical records and laboratory results, which in most jurisdictions you are entitled to and which may go back years. Recording every result yourself, with date, time, fasting state, laboratory and context. Keeping it in one place in a format you control. Using the same laboratory across time.
Cost: essentially nothing, plus the discipline of recording at the time.
Value: after five years you have a personal reference range; after ten you have a rate of change and a seasonal pattern. Neither is purchasable, and both are lost by switching platforms every two years.
This is the want where the alternative is most clearly superior, and the one most often satisfied by a subscription that does it worse.
Want Five: Reassurance
Worth naming honestly, because it is a common motivation and testing serves it badly.
Why broad testing does not reassure: reference ranges include the central 95 per cent of a healthy population, so a large panel reliably produces findings that require explanation. The result is frequently more anxiety rather than less, plus cascade investigation.
What actually addresses the underlying concern, depending on what it is: age-appropriate cancer screening through established programmes, which is unglamorous and among the highest-value health actions available. Properly measured blood pressure, which is silent and consequential. A one-off lipoprotein(a) and family history, which settle the inherited risk question. A dermatological examination where skin cancer risk factors are present. An audiogram from midlife.
If the concern is a specific symptom, that is a clinical assessment, and a panel is a detour.
If the concern is general health anxiety, more testing predictably worsens it, and that is worth recognising before buying another panel.
The uncomfortable observation: repeat comprehensive testing in a well person is one of the more reliable ways to generate worry, and the market for it depends partly on that loop.
The Complete Alternative Stack
What to do instead of subscribing to a testing service, in order:
Request your existing records. Free, and frequently reveals that measurement was never the gap.
Ask your clinician for the four omissions: apoB, lipoprotein(a) once, fasting insulin, urine albumin to creatinine ratio. State the reason.
Buy a validated blood pressure cuff, a tape measure and a grip dynamometer. Together they cost less than a single consumer panel and predict more than most of what one measures.
Build the record yourself, numbers with units, conditions noted, one place, one laboratory.
Book the unglamorous things: age-appropriate cancer screening, a dental check, an audiogram from midlife, and a DEXA at the guideline age.
Use a consumer service only for genuine access gaps, choosing analytes rather than packages, with venous collection where possible.
Spend the difference on the foundation, which for most people means whatever makes training and sleep more likely to happen.
That covers every one of the five wants, at a fraction of the cost, and it produces a record you own rather than one you rent.
The AEONNN Perspective
AEONNN's interest here is in the decision layer rather than the testing layer, which makes this a straightforward assessment. Of the five things people buy a testing service for, only access to specific omitted analytes genuinely requires one in most systems, and the usual four omissions, apoB, lipoprotein(a) once, fasting insulin and a urine albumin to creatinine ratio, are inexpensive standard tests a clinician will often order when the reason is stated.
The want the platform sees most often unrecognised is interpretation, and the honest answer is that it is learnable rather than purchasable: reading position within ranges rather than flags, checking draw conditions, comparing to your own previous values, and identifying the upstream pattern rather than counting findings. Much of this Journal exists for that.
On the longitudinal record, the alternative is clearly better and the platform should say so. A record held by a provider, in their format, often as scores rather than numbers, ends when the subscription does. Requesting your own past results, recording numbers with conditions, and using one laboratory costs almost nothing and produces an asset you own. And the reassurance want is the one testing serves worst, since a broad panel in a well person reliably produces findings and more anxiety.
Pillar Matrix mapping
Database Matrix layers
- Meta / Consensus Layer (JAMA, BMJ, specialty society positions)
- Quality / Formulation Layer (ConsumerLab, Labdoor)
- Regulatory Layer (EFSA, FDA, EMA)
- Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
Frequently Asked
What do people actually buy a testing service for?
Access to analytes routine care omits, convenience, interpretation, a longitudinal record, or reassurance. Only the first genuinely requires a consumer service in most systems.
Which analytes should I ask my clinician for?
Apolipoprotein B, lipoprotein(a) once, fasting insulin, and a urine albumin to creatinine ratio. Free T4 alongside TSH and thyroid antibodies once are also commonly omitted.
What are the costs of home collection?
Finger-prick sampling brings haemolysis, small volume and dilution from squeezing, and posted samples affect homocysteine, potassium and glucose. There is no flag on the report saying so.
Is a testing service a good way to buy interpretation?
Poorly. Reports are generated at scale, emphasise flags rather than patterns, and where the service sells products the interpretation is not independent of the catalogue.
How should I build a longitudinal record?
Request your own past records, record every result with date, conditions and laboratory, keep it in one place in a format you control, and use the same laboratory across time.
Does testing provide reassurance?
Usually the opposite. A broad panel in a well person reliably produces findings requiring explanation, which generates anxiety and cascade investigation.
What should I buy instead?
A validated blood pressure cuff, a tape measure and a grip dynamometer cost less than one consumer panel and predict more than most of what one measures.
Evidence and review
Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.